Total Visits
| Views | |
|---|---|
| Primary ... | 81 |
Total Visits Per Month
| June 2025 | July 2025 | August 2025 | September 2025 | October 2025 | November 2025 | December 2025 | |
|---|---|---|---|---|---|---|---|
| Primary ... | 2 | 1 | 1 | 6 | 10 | 8 | 0 |
File Visits
| Views | |
|---|---|
| primary_results_characterization_patients_exceptional_outcomes_a_phase_1b_study_combining_parp_mek_inhibition_anti_pd_l1_brca_wild_type_platinum_sensitive_recurrent_ovarian_cancer_2024.pdf | 50 |
Top country views
| Views | |
|---|---|
| United States | 27 |
| Singapore | 16 |
| Spain | 10 |
| Germany | 4 |
| Hong Kong | 4 |
| Brazil | 3 |
| Ireland | 3 |
| Austria | 2 |
| Finland | 2 |
| United Kingdom | 2 |
Top cities views
| Views | |
|---|---|
| Singapore | 11 |
| Almont | 4 |
| Ashburn | 4 |
| Hong Kong | 4 |
| Barcelona | 3 |
| Dublin | 3 |
| Nuremberg | 3 |
| Helsinki | 2 |
| Baghdad | 1 |
| Düsseldorf | 1 |



